Latest filingSep 04, 2026Most recent Form 4
EDIT
Editas Medicine, Inc.
Insider activity for last month from 08/05 to 09/05. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$1.90M3 sells
Net open-market-$1.90M3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period3transactions
- S · Open-market sells · dominant3 · 100%
Activity by reported role
A joint filing can contribute to multiple roles5transactions
- Chief executive officer · dominant1 · 20%
- Chief financial officer1 · 20%
- CSO1 · 20%
- EVP1 · 20%
- SVP1 · 20%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (3)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeO'Neill Gilmore NeilCommon Stock · Direct
243,189Sep 03, 2026
Parison AmyCommon Stock · Direct
13,839Sep 03, 2026
Burkly LindaCommon Stock · Direct
61,660Sep 03, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 05 → Sep 05
LessMore
Top insiders
By absolute net value across the selected period- ON-$15.6k
- BL-$2.2k
- PA-$1.4k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
EDIT transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| EDIT | Burkly Linda | EVPCSO | sale | 709 | -$215k | S | — | — | 09/04 | 09/03 |
| EDIT | Parison Amy | SVPCFO | sale | 453 | -$137k | S | — | — | 09/04 | 09/03 |
| EDIT | O'Neill Gilmore Neil | CEO | sale | 5.12k | -$1.55M | S | — | — | 09/04 | 09/03 |
Editas Medicine, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Editas Medicine, Inc.?
Burkly Linda, Parison Amy, O'Neill Gilmore Neil.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Burkly Linda reported a sale on Sep 03, 2026 valued at $215k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $19,091.83. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.